| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-05 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.001 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |